Does IMIGLUCERASE Cause Poor venous access? 43 Reports in FDA Database

Q: Does IMIGLUCERASE cause Poor venous access?

43 reports of Poor venous access have been filed with the FDA for IMIGLUCERASE, representing 1.7% of all IMIGLUCERASE adverse event reports.

Q: How dangerous is Poor venous access from IMIGLUCERASE?

Of 43 reports, 1 (2.3%) resulted in death and 12 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Poor venous access have been filed in association with IMIGLUCERASE (Cerezyme). This represents 1.7% of all adverse event reports for IMIGLUCERASE.

Reports of Poor venous access with IMIGLUCERASE

1.7%

of all IMIGLUCERASE reports

Deaths

Hospitalizations

How Dangerous Is Poor venous access From IMIGLUCERASE?

Of the 43 reports, 1 (2.3%) resulted in death, 12 (27.9%) required hospitalization.

Is Poor venous access Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IMIGLUCERASE. However, 43 reports have been filed with the FAERS database.

What Other Side Effects Does IMIGLUCERASE Cause?

Exposure during pregnancy (152) Pyrexia (133) Fatigue (122) Weight increased (118) Malaise (103) Weight decreased (95) Dizziness (92) Dyspnoea (80) Pain (80) Pneumonia (80)

What Other Drugs Cause Poor venous access?

VEDOLIZUMAB (1,043) INFLIXIMAB (917) INFLIXIMAB-DYYB (782) ECULIZUMAB (555) HUMAN IMMUNOGLOBULIN G (504) NATALIZUMAB (422) RITUXIMAB (299) TOCILIZUMAB (287) METHOTREXATE (257) ABATACEPT (249)

Which IMIGLUCERASE Alternatives Have Lower Poor venous access Risk?

IMIGLUCERASE vs IMIPENEM IMIGLUCERASE vs IMIPRAMINE IMIGLUCERASE vs IMIQUIMOD IMIGLUCERASE vs IMITREX IMIGLUCERASE vs IMMUNE GLOBULIN NOS

IMIGLUCERASE Full Profile All Poor venous access Reports All Drugs Causing Poor venous access IMIGLUCERASE Demographics